Effectively, the exposure of cancer cells to our complexes evidently reduced the intracellular expression of vimentin with respect to the vehicle-treated cells, with a higher effect produced by complex 1, able to reduce the protein expression by almost 6 times, whereas the complex 2 exerted a lower effect (two times lower vs. CTRL). Here, VIM is linked to cancer.